KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

ORTHOPEDIATRICS CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$22.03+0.08 (+0.36%)

Close on Oct 19, 2026

Market cap: $529.79M
P/E (TTM): –
Dividend yield: –

ORTHOPEDIATRICS CORP income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31
Revenue	236	205	149	122	98	71	73	58	46	37	31
Cost of Revenue	64	56	37	32	25	16	18	15	11	11	9.37
Gross Profit	173	149	111	91	73	55	55	43	34	26	22
Research & Development	9.10	11	11	8.45	5.54	5.27	5.75	4.73	3.42	2.22	1.79
Selling, General & Admin	193	167	126	104	86	70	58	48	37	28	26
Selling & Marketing	73	64	53	46	40	32	31	27	21	17	15
General & Administrative	120	103	73	58	46	38	27	21	17	12	11
Advertising Expenses	3.43	2.40	2.41	1.91	0.90	1.23	1.42	0.98	1.13	0.92	0.83
Operating Expenses	212	184	138	116	91	82	64	52	41	32	28
Operating Income	-39	-35	-27	-25	-18	-27	-9.08	-9.55	-6.47	-6.13	-6.59
Interest Expense	6.00	2.62	-0.20	2.42	0.06	3.41	3.54	2.26	2.49	1.48	1.23
Other Non-Operating Income	0.05	-6.92	5.44	22	0.64	-6.91	-3.61	-2.47	-2.46	-0.45	-1.26
Merger & Restructuring Charges	5.60	3.65	0	0	–	–	–	–	–	–	–
Asset Impairment Charges	6.51	1.84	0.99	0	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	0	0	-0.21	0	0	0	-0.04
Legal Settlements	–	–	0	0	-0.15	-6.34	0	0	–	–	–
Pretax Income	-39	-42	-21	-3.69	-17	-34	-13	-12	-8.95	–	–
Income Tax Expense	0.46	-4.11	-0.34	-4.95	-1.13	-0.72	0	0	0	0	0
Income from Continuing Operations	-40	-38	-21	1.26	-16	-33	-13	-12	-8.93	-6.57	-7.85
Income from Discontinued Operations	–	–	–	–	0	0	-1.05	0	0	0	-0.04
Net Income	-40	-38	-21	1.26	-16	-33	-14	-12	-8.93	-6.57	-7.89
Net Income to Common	-40	-38	-21	1.24	-16	-33	-14	-12	-24	-12	-13
EPS (Basic)(per share)	-1.69	-1.64	-0.92	0.06	-0.84	-1.82	-0.94	-0.96	-5.86	-7.14	-7.27
EPS (Diluted)(per share)	-1.69	-1.64	-0.92	0.06	-0.84	-1.82	-0.94	-0.96	-5.86	-7.14	-7.27
Shares Outstanding (Basic, Weighted)(shares)	23	23	23	21	19	18	15	13	4.02	1.74	1.74
Shares Outstanding (Diluted, Weighted)(shares)	23	23	23	21	19	18	15	13	4.02	1.74	1.74
EBITDA	-18	-16	-9.37	-12	-7.34	-19	-4.41	-6.66	-4.07	-4.23	-4.74
Net Interest Income	–	–	0.20	-2.42	-2.25	-3.41	-3.54	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 73.7%
Operating margin: -11.9%
Net margin: -15.7%
Return on equity, FY2025: -11.3%

Financial strength

Current ratio: 4.78
Debt to equity: 0.30
Debt to assets: 19.9%
Cash to current liabilities: 32.2%

Valuation

P/E ratio: –
Price to sales: 2.10
Price to book: 1.54
Dividend yield: –